Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

3187

Actual shortage: 257 (8%)
Anticipated shortage: 1 (0%)
Avoided shortage: 10 (0%)
Resolved: 2919 (92%)

Discontinuation Reports

435

To be discontinued: 2 (0%)
Discontinued: 410 (94%)
Reversed: 23 (5%)

Late reports

482 (13%)

Overdue reports

12 (5%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-BUPRENORPHINE/NALOXONE 2MG 0.5MG TABLET Resolved 2021-05-20 2021-06-03 139725
TEVA-BUPRENORPHINE/NALOXONE 2MG 0.5MG TABLET Resolved 2021-06-03 2021-06-10 140363
TEVA-BUPRENORPHINE/NALOXONE 0.5MG 2MG TABLET Resolved 2021-08-27 2021-09-16 144704
TEVA-BUPRENORPHINE/NALOXONE 2MG 0.5MG TABLET Resolved 2022-08-18 2022-12-02 167203
TEVA-BUPRENORPHINE/NALOXONE 2MG 8MG TABLET Resolved 2022-12-01 2022-12-22 176824
TEVA-BUPRENORPHINE/NALOXONE 2MG 0.5MG TABLET Resolved 2024-03-07 2024-06-27 221534
TEVA-BUPRENORPHINE/NALOXONE 2MG 8MG TABLET Resolved 2024-03-07 2024-06-27 221537
TEVA-BUPRENORPHINE/NALOXONE 2MG 0.5MG TABLET Actual shortage 2025-08-29 2025-10-30 266196
TEVA-BUPRENORPHINE/NALOXONE 8MG 2MG TABLET Actual shortage 2025-08-29 2025-10-30 266199
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2020-07-09 2020-08-27 119889
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2020-07-16 2021-09-30 120473
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2021-02-11 2021-04-29 133770
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2021-02-11 2021-05-27 133776
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2021-06-10 2021-09-30 140675
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2022-01-27 2022-11-12 153709
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2022-02-17 2022-03-24 155137
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2022-03-10 2022-03-24 156407
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2022-05-12 2022-11-12 160427
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2022-05-12 2022-11-12 160432
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2023-04-27 2023-06-09 190728

Showing 921 to 940 of 3187

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ACT VENLAFAXINE XR 37.5MG CAPSULE (EXTENDED RELEASE) Discontinued 2018-10-22 2018-10-22 65298
ACT VENLAFAXINE XR 150.0MG CAPSULE (EXTENDED RELEASE) Discontinued 2018-10-22 2018-10-22 65305
ACT ZOPICLONE 5MG TABLET Discontinued 2018-10-22 2018-10-22 65191
ACT ZOPICLONE 7.5MG TABLET Discontinued 2018-10-22 2018-10-22 65213
ACT ZOPICLONE 7.5MG TABLET Discontinued 2018-10-22 2018-10-22 65218
AERMONY RESPICLICK 55MCG POWDER (METERED DOSE) Discontinued 2024-11-05 2024-11-05 242101
AERMONY RESPICLICK 113MCG POWDER (METERED DOSE) Discontinued 2025-05-28 2025-05-28 258571
AERMONY RESPICLICK 232MCG POWDER (METERED DOSE) Discontinued 2025-09-02 2025-09-02 266350
ALERTEC 100MG TABLET Discontinued 2025-05-28 2025-05-28 258777
ALLERNIX 25MG TABLET Discontinued 2025-05-28 2025-05-28 258595
ALLERNIX EXTRA STRENGTH 50MG TABLET Discontinued 2025-05-28 2025-05-28 258562
AZILECT 1MG TABLET Reversed 2025-05-28 2025-06-04 258705
AZILECT 1MG TABLET Reversed 2025-05-28 2025-06-04 258771
BALMINIL DM (3MG/ML SUCROSE FREE) 15MG SYRUP Discontinued 2025-05-28 2025-05-28 258741
BALMINIL EXPECTORANT (SUCROSE FREE) 100MG SYRUP Discontinued 2025-05-28 2025-05-28 258750
BORTEZOMIB FOR INJECTION 3.5MG POWDER FOR SOLUTION Discontinued 2025-04-29 2025-04-29 256094
CALMYLIN ACE 10MG 7.5MG 100MG SYRUP Discontinued 2024-06-28 2024-06-29 231574
CEFAZOLIN FOR INJECTION 0.5G POWDER FOR SOLUTION Discontinued 2019-08-08 2019-08-08 91175
CEFAZOLIN FOR INJECTION 10G POWDER FOR SOLUTION Discontinued 2023-11-27 2023-11-27 211558
CEFOXITIN FOR INJECTION 10G POWDER FOR SOLUTION Discontinued 2020-05-14 2020-05-14 115088

Showing 61 to 80 of 435